Group 1 - The company, Huizhong Co., announced the establishment of a wholly-owned subsidiary in Australia, with a maximum investment amount of 20 million RMB or equivalent foreign currency [2] - The decision was made during the 18th meeting of the fifth board of directors and the 13th meeting of the fifth supervisory board held on April 17, 2025 [2] - The company has obtained the necessary approvals, including the "Overseas Investment Certificate" from the Hebei Provincial Department of Commerce and the company registration certificate from the Australian Securities and Investments Commission [2]

证券代码：300371 证券简称：汇中股份 公告编号：2025-062 汇中仪表股份有限公司 关于公司澳大利亚全资子公司完成设立登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、对外投资概述 汇中仪表股份有限公司（以下简称"公司"）于 2025 年 4 月 17 日召开第五届 董事会第十八次会议、第五届监事会第十三次会议，审议通过了《关于公司拟对 外投资设立澳大利亚全资子公司的议案》。经审议，同意公司使用自有资金对外 投资设立澳大利亚全资子公司，投资金额不超过 2,000 万元人民币或等值外币。 具体内容详见公司于 2025 年 4 月 18 日在巨潮资讯网（www.cninfo.com.cn）披露 的《关于公司拟对外投资设立澳大利亚全资子公司的公告》（公告编号：2025-036）。 本次澳大利亚全资子公司的设立符合《深圳证券交易所创业板股票上市规则》 及《公司章程》的相关规定。本次对外投资事项不构成关联交易。 二、设立登记情况 注册地址：维多利亚州 注册资本：100 澳大利亚元（根据业务的需求分阶段增资） 股权结构：汇中仪表股份有限公司持有 1 ...

Core Insights - The 2025 mid-year reports for listed instrument companies show a mixed performance, with 40 out of 50 companies reporting revenue growth, while 34 companies reported an increase in net profit [1][4][5] - Significant disparities in performance exist among companies, with some experiencing substantial profit growth while others face severe declines [3][7][9] Revenue Performance - Total revenue for the 50 listed instrument companies reached approximately 65.965 billion, with 40 companies showing revenue growth, and 14 companies achieving growth rates above 20% [1][4] - Companies with revenues exceeding 1 billion include: - 汇川技术 (Hui Chuan Technology) 20.509 billion - 三星医疗 (Samsung Medical) 7.972 billion - 川仪股份 (Chuan Yi Co.) 3.281 billion - 华测检测 (Hua Ce Testing) 2.96 billion - 科陆电子 (Ke Lu Electronics) 2.573 billion [5] Profit Performance - Total net profit for the 50 companies was approximately 8.735 billion, with 34 companies reporting profit growth, and 10 companies achieving growth rates above 50% [1][4] - Companies with net profits exceeding 1 billion include: - 汇川技术 (Hui Chuan Technology) 2.968 billion - 三星医疗 (Samsung Medical) 1.230 billion [5] Notable Performers - High performers include: - 高德红外 (Gao De Infrared) with a net profit growth of 906.85% and revenue growth of 68.24% [6] - 汇中股份 (Hui Zhong Co.) with a net profit growth of 102.72% and revenue growth of 51.67% [5] - 科陆电子 (Ke Lu Electronics) with a net profit growth of 579.14% [5] Underperformers - Companies facing significant declines include: - 聚光科技 (Ju Guang Technology) with a net profit decline of 210.86% [7] - 秦川物联 (Qin Chuan IoT) with a net profit decline of 209.73% [7] - 万讯自控 (Wan Xun Control) with a net profit decline of 253.92% [7] - 蓝盾光电 (Lan Dun Optoelectronics) with a net profit decline of 1877.03% [7] Market Trends - The performance disparity among companies is expected to continue, although overall A-share profitability may improve marginally due to supportive macroeconomic policies [9]

公司发布的半年报数据显示，上半年公司共实现营业收入2.13亿元，同比增长51.67%，实现净利润 4155.80万元，同比增长102.72%，基本每股收益为0.2091元，加权平均净资产收益率3.68%。（数据 宝） 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） 汇中股份9月1日披露，截至8月31日公司股东户数为11077户，较上期（8月20日）减少1159户，环比降 幅为9.47%。这已是该公司股东户数连续第5期下降。 证券时报·数据宝统计，截至发稿，汇中股份收盘价为14.04元，上涨3.31%，本期筹码集中以来股价累 计下跌3.37%。具体到各交易日，3次上涨，5次下跌。 ...

Core Viewpoint - Huizhong Co., Ltd. (300371) has achieved significant growth in both revenue and net profit due to its deep technical expertise in ultrasonic flow measurement and global strategic layout, despite facing challenges in the domestic market [2] Financial Performance - In the first half of 2025, the company's operating revenue reached 213 million yuan, a year-on-year increase of 51.67% - The net profit attributable to shareholders was 41.558 million yuan, up 102.72% year-on-year - The net profit after deducting non-recurring gains and losses was 36.335 million yuan, a substantial increase of 122.31% year-on-year - Basic earnings per share were 0.21 yuan, an increase of 103.60% year-on-year [2] Overseas Market Growth - The overseas market has become a key driver for the company's performance, with overseas business revenue reaching 73.5964 million yuan, a staggering increase of 1920.58% year-on-year - Gross margin in the overseas market improved to 49.79%, an increase of 11.08 percentage points compared to the same period last year [3] Strategic Initiatives - The company has established a subsidiary in Australia and formed a strategic partnership with Italy's Almaviva Bluebit to enhance its overseas channel network - Continuous improvement in overseas market expansion capabilities and personalized service levels has effectively shaped the high-end product image of ultrasonic household water meters in international markets [3] Product Development and Innovation - The company invested 18.0814 million yuan in R&D in the first half of 2025, a year-on-year increase of 19.11% - Four new patents and seven software copyrights were authorized during the reporting period, bringing the total number of effective patents to 132 [5] Technological Advancements - The company is advancing both hardware and software products, focusing on optimizing performance and enhancing overseas adaptability - The SaaS platform has served 1,080 users in the water supply and heating sectors, a 0.9% increase from the previous year [6] Smart Manufacturing and Efficiency - The company employs a PDCA model for production management, focusing on quality, efficiency, and cost control - It has made breakthroughs in production capacity, quality, efficiency, and safety through self-built supply chains and digital enhancements [7] Future Outlook - The company aims to strengthen its brand influence and product competitiveness while optimizing management to enhance profitability [7]

Core Insights - The company reported a significant increase in revenue and net profit for the first half of 2025, indicating strong financial performance [1][3] - Key financial metrics such as gross margin, return on equity (ROE), and asset turnover have shown positive trends compared to the previous year [3] Financial Performance - The company's total revenue reached 213 million yuan, an increase of 72.69 million yuan, representing a year-on-year growth of 51.67% [1] - The net profit attributable to shareholders was 41.56 million yuan, up by 21.06 million yuan, reflecting a year-on-year increase of 102.72% [1] - Operating cash flow showed a net inflow of 58.97 million yuan, an increase of 67.28 million yuan compared to the same period last year, marking two consecutive years of growth [1] Key Ratios - The latest debt-to-asset ratio stands at 8.10%, a decrease of 0.82 percentage points from the same period last year [3] - The gross margin is reported at 48.68%, an increase of 1.08 percentage points from the previous quarter [3] - Return on equity (ROE) is at 3.64%, up by 1.73 percentage points year-on-year [3] Earnings Per Share - The diluted earnings per share (EPS) is 0.21 yuan, an increase of 0.11 yuan, representing a year-on-year growth of 103.60% [3] Efficiency Metrics - The total asset turnover ratio is 0.17 times, an increase of 0.06 times compared to the same period last year, reflecting a year-on-year growth of 47.73% [3] - The inventory turnover ratio is 0.53 times, up by 0.21 times year-on-year, indicating a growth of 68.30% [3] Shareholder Structure - The number of shareholders is 8,783, with the top ten shareholders holding 126 million shares, accounting for 62.47% of the total share capital [3] - The largest shareholder, Zhang Lixin, holds 37.95% of the shares [3]

（记者 张喜威） 每经AI快讯，汇中股份（SZ 300371，收盘价：13.97元）8月25日晚间发布公告称，公司第六届第二次 董事会会议于2025年8月25日在公司四楼会议室召开。会议审议了《关于公司2025年半年度报告及其摘 要的议案》等文件。 2024年1至12月份，汇中股份的营业收入构成为：仪器仪表制造业占比100.0%。 每经头条（nbdtoutiao）——租下2.5万亩"试验田"，兽医学博士在非洲种粮：首季亩产250斤，打算扩至 10万亩，月薪1~2万元招人 ...

证券代码：300371 证券简称：汇中股份 公告编号：2025-058 汇中仪表股份有限公司 第六届董事会第二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况： 汇中仪表股份有限公司（以下简称"公司"）第六届董事会第二次会议于 2025 年 8 月 25 日以现场会议方式在公司四楼会议室召开。本次会议由董事长张力新 先生提议召开。会议通知于 2025 年 8 月 14 日以书面通知方式发出。公司现有董 事 9 人，现场出席董事 9 人，会议由董事长张力新先生主持，本次会议的召开符 合《中华人民共和国公司法》等法律、法规以及《公司章程》的规定。 二、董事会会议审议情况 经与会董事认真审议，一致审议通过如下议案： 1、审议通过《关于公司 2025 年半年度报告及其摘要的议案》 公司《2025 年半年度报告》及《2025 年半年度报告摘要》的具体内容详见 公司 2025 年 8 月 26 日于中国证监会指定网站巨潮资讯网（www.cninfo.com.cn） 上发布的公告。 董事会 本议案已经公司董事会审计委员会审议通过。 表决 ...

| | | 占用方与上 | 上市公司 | 年期初 2025 | 2025 年上半年 占用累计发生 | 年上半 2025 | 年上半 2025 | 年 2025 6 | 占用形成 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性资金占用 | 资金占用方名称 | 市公司的关 | 核算的会 | 占用资金余 | 金额（不含利 | 年占用资金的 | 年偿还累计 | 月末占用 | 占用性质 原因 | | | | 联关系 | 计科目 | 额 | | 利息(如有) | 发生金额 | 资金余额 | | | | | | | | 息） | | | | | | 控股股东、实际控 | | | | | | | | | | | 制人及其附属企业 | | | | | | | | | 非经营性占用 | | 小计 | - | - | - | | | | | | - - | | 前控股股东、实际 | | | | | | | | | 非经营性占用 | | 控制人及其附属企 | | | | | | | | | | | 业 | | | | | | | | | | ...

汇中仪表股份有限公司 关于举行 2025 年半年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 汇中仪表股份有限公司（以下简称"公司"）2025年半年度报告全文及其摘要 于2025年8月26日在巨潮资讯网（www.cninfo.com.cn）披露。为方便投资者进一 步了解公司经营情况及未来发展规划，公司将于2025年9月5日（星期五）下午 15:00-16:30在深圳证券交易所互动易平台.云访谈栏目（ http://irm.cninfo.com.cn） 举办业绩说明会，与投资者进行沟通和交流，在信息披露允许范围内就投资者普 遍关注的问题进行回答。 特此公告。 汇中仪表股份有限公司 证券代码：300371 证券简称：汇中股份 公告编号：2025-061 为充分尊重投资者、提升交流的针对性，现就公司2025年半年度网上业绩说 明会提前向投资者公开征集问题，投资者可访问 http://irm.cninfo.com.cn，进入 问题征集专题页面。 出席本次年度业绩说明会的人员有：公司董事、总经理、财务总监冯大鹏先 生、董事会秘书李俊杰先生、独立 ...